Percutaneous coronary intervention in native vessels with angiographically visible thrombus: Temporal trends and impact of drug-eluting stents

JACC: Cardiovascular Interventions

Volumn 3, Issue 9, 2010, Pages 937-946

  Srinivasan, Manivannan ^a   Rihal, Charanjit S ^a   Singh, Mandeep ^a   Lennon, Ryan J ^b   Holmes, David R ^a   Prasad, Abhiram ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

outcomes; percutaneous coronary intervention; stents; thrombus

Indexed keywords

ADULT; ANGIOGRAPHY; ARTICLE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; THROMBUS; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77956629323     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.06.013     Document Type: Article

References (39)

1. A. Prasad, and B.J. Gersh Management of microvascular dysfunction and reperfusion injury Heart 91 2005 1530 1532
2. M. Singh, P.B. Berger, and H.H. Ting Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience) Am J Cardiol 88 2001 1091 1096
3. C.T. Sherman, F. Litvack, and W. Grundfest Coronary angioscopy in patients with unstable angina pectoris N Engl J Med 315 1986 913 919
4. M.A. DeWood, J. Spores, and R. Notske Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction N Engl J Med 303 1980 897 902
5. G. Sianos, M.I. Papafaklis, and J. Daemen Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden J Am Coll Cardiol 50 2007 573 583
6. T.F. Luscher, J. Steffel, and F.R. Eberli Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 2007 1051 1058
7. D.W. Park, S.W. Park, and K.H. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356
8. C.W. Hwang, A.D. Levin, M. Jonas, P.H. Li, and E.R. Edelman Thrombosis modulates arterial drug distribution for drug-eluting stents Circulation 111 2005 1619 1626
9. M. Singh, R.J. Lennon, D.R. Holmes Jr., M.R. Bell, and C.S. Rihal Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention J Am Coll Cardiol 40 2002 387 393
10. J.C. Blankenship, G. Tasissa, J.C. O'Shea ESPRIT Investigators Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial J Am Coll Cardiol 38 2001 653 658
11. M.M. Khan, S.G. Ellis, and F.V. Aguirre Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications J Am Coll Cardiol 31 1998 31 36
12. P.J. de Feyter, M. van den Brand, G.J. Laarman, R. van Domburg, P.W. Serruys, and H. Suryapranata Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty Frequency, prediction, clinical course, management, and follow-up Circulation 83 1991 927 936
13. K.M. Detre, D.R. Holmes Jr., and R. Holubkov Incidence and consequences of periprocedural occlusion The 19851986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Circulation 82 1990 739 750 (Pubitemid 20316724)
14. S.G. Ellis, G.S. Roubin, and S.B. King III Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty Circulation 77 1988 372 379
15. M. Singh, C.S. Rihal, and B.J. Gersh Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience Circulation 115 2007 2835 2841
16. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
17. B.J. Doyle, H.H. Ting, and M.R. Bell Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 J Am Coll Cardiol Intv 1 2008 202 209
18. S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
19. A. Prasad, C.S. Rihal, R.J. Lennon, H.J. Wiste, M. Singh, and D.R. Holmes Jr Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic J Am Coll Cardiol 49 2007 1611 1618
20. M.S. Sabatine, D.A. Morrow, and R.P. Giugliano Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/nonST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial Circulation 109 2004 874 880
21. G.W. Stone, C.L. Grines, D.A. Cox Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
22. EPISTENT Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Lancet 352 1998 87 92
23. EPILOG Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization N Engl J Med 336 1997 1689 1696
24. EPIC Investigation Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty N Engl J Med 330 1994 956 961
25. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
26. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
27. B. Kunadian, J. Dunning, K. Vijayalakshmi, A.R. Thornley, and M.A. de Belder Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial infarction Catheter Cardiovasc Interv 69 2007 488 496
28. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947
29. D.R. Holmes Jr., M.B. Leon, and J.W. Moses Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640
30. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
31. M.C. Morice, P.W. Serruys, J.E. Sousa RAVEL Study Group A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
32. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
33. A. Kastrati, A. Dibra, and C. Spaulding Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction Eur Heart J 28 2007 2706 2713 (Pubitemid 350139205)
34. G.W. Stone, B. Witzenbichler, G. Guagliumi HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
35. L. Mauri, T.S. Silbaugh, and P. Garg Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 2008 1330 1342
36. A. Okamura, H. Ito, and K. Iwakura Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: quantitative study with Doppler guidewire J Am Coll Cardiol Intv 1 2008 268 276
37. H.K. Yip, M.C. Chen, and H.W. Chang Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon Chest 122 2002 1322 1332
38. M. Srinivasan, C. Rihal, D.R. Holmes, and A. Prasad Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes Circulation 119 2009 1311 1319
39. P.S. Teirstein, R.A. Schatz, S.J. DeNardo, E.E. Jensen, and A.D. Johnson Angioscopic versus angiographic detection of thrombus during coronary interventional procedures Am J Cardiol 75 1995 1083 1087